MeiraGTx grants 70,000 RSUs to executive

Naylor Stuart reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Naylor Stuart reported acquisition or exercise transactions in this Form 4 filing.

MeiraGTx Holdings plc reported that Chief Scientific Officer of Ophthalmology Stuart Naylor received a grant of 70,000 Restricted Share Units. Each RSU represents the right to receive one ordinary share upon vesting. Half of the award vests on the second anniversary of the grant, with 25% vesting on each of the third and fourth anniversaries.

Insider Trade Summary

Grant/Award: 70,000 shares

Grant/Award 1 txn

Insider Naylor Stuart

Role CHIEF SCI OFCR, OPHTHALMOLOGY

Type	Security	Shares	Price	Value
Grant/Award	Restricted Share Units	70,000	$0.00	$0.00

Holdings After Transaction: Restricted Share Units — 70,000 contracts (Direct)

Footnotes (2)

1. F1. Each restricted share unit converts into one ordinary share upon vesting.
2. F2. Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date.

Key Figures

RSUs granted: 70,000 units RSUs post-transaction: 70,000 units Vesting on 2nd anniversary: 50% of award +3 more

6 metrics

RSUs granted 70,000 units Restricted Share Units granted to CSO of Ophthalmology

RSUs post-transaction 70,000 units Total Restricted Share Units held after grant

Vesting on 2nd anniversary 50% of award First vesting tranche of RSU grant

Vesting on 3rd anniversary 25% of award Second vesting tranche of RSU grant

Vesting on 4th anniversary 25% of award Final vesting tranche of RSU grant

RSU grant price $0.0000 per unit Stated transaction price for RSU grant

Key Terms

Restricted Share Units, ordinary share, vesting, grant date

4 terms

Restricted Share Units financial

"Each restricted share unit converts into one ordinary share upon vesting."

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

ordinary share financial

"Each restricted share unit converts into one ordinary share upon vesting."

An ordinary share is a unit of ownership in a company that gives the holder a stake in its profits and usually the right to vote on key decisions. Think of it like a slice of a pizza where each slice entitles you to a portion of what’s left after bills are paid; value can rise or fall with the business and may pay dividends, so it matters to investors for income, growth and control.

vesting financial

"Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

grant date financial

"Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date"

The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MeiraGTx (MGTX) disclose for Stuart Naylor?

MeiraGTx disclosed that Chief Scientific Officer of Ophthalmology Stuart Naylor received a grant of 70,000 Restricted Share Units. These RSUs were awarded at no purchase price and convert into ordinary shares as they vest over a multi-year schedule tied to the grant date.

How many Restricted Share Units were granted to the MeiraGTx (MGTX) executive?

The executive received 70,000 Restricted Share Units. Each unit converts into one ordinary share upon vesting, giving the officer the right to receive 70,000 ordinary shares in total if all vesting conditions tied to the grant schedule are satisfied over time.

What is the vesting schedule for the MeiraGTx (MGTX) RSU grant?

Fifty percent of the 70,000-unit RSU award vests on the second anniversary of the grant date. The remaining units vest in two equal tranches of 25% each, on the third and fourth anniversaries, creating a four-year, back-weighted vesting structure for the award.

Do the MeiraGTx (MGTX) Restricted Share Units have an exercise price?

The Restricted Share Units were granted with a stated price of 0.0000 per unit, meaning no cash exercise price is required. Upon vesting, each RSU converts into one ordinary share, effectively delivering shares without an additional purchase payment by the executive.

What does each MeiraGTx (MGTX) RSU convert into upon vesting?

Each Restricted Share Unit converts into one ordinary share of MeiraGTx upon vesting. This means the 70,000 RSUs, if fully vested, would result in 70,000 ordinary shares being issued to the executive in accordance with the vesting schedule described in the filing footnotes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/29/2026 - 09:17 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Naylor Stuart

(Last) (First) (Middle)

655 THIRD AVENUE

SUITE 1115

(Street)

NEW YORK NEW YORK 10017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MeiraGTx Holdings plc [ MGTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF SCI OFCR, OPHTHALMOLOGY

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Share Units	(1)	06/25/2026		A		70,000		(2)	(2)	Ordinary Shares	70,000	$0	70,000	D

Explanation of Responses:

1. Each restricted share unit converts into one ordinary share upon vesting.

2. Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date.

	/s/ Richard Giroux, Attorney-in-Fact for Stuart Naylor	06/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)